<![CDATA[Objective: To evaluate the "false negative" of VIA in our study population compared to HPV DNA test as the reference test or gold standard.
Method: We processed the cervical swab from 1,279 patients with
negative VIA and detected the HPV DNA by using INNO-Lipa HPV
DNA test.
Result: From 1,279 women with negative VIA, 65 samples were excluded because of incomplete data and duplicate examination. From
the remaining 1,214 women with negative VIA, 39 samples were
confirmed to be positive for HPV DNA by both PCR and hybridization,
leading to a "false negative" result of 3.21%.
Conclusion: This study shows VIA as a very effective method for
cervical cancer screening. VIA gives an excellent result, particularly
for ectocervix, with minimal cost. Therefore, it is very suitable to be
used as cervical cancer screening in developing countries like Indonesia.
[Indones J Obstet Gynecol 2014; 4: 216-219]
Keywords: cervical cancer, HPV DNA, negative VIA, screening, VIA]]>
Copyrights © 2014
